Skip to content

Thromboelastometry and Ischemic Stroke (ThromboPredict)

Interest of Thromboelastometry as a Biomarker of Post-thrombolysis or Post-thrombectemia Revascularization Success in Ischemic Stroke: a Prospective, Single-center, Observational Study in an Emergency Department

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04870684
Enrollment
200
Registered
2021-05-03
Start date
2021-05-01
Completion date
2024-05-01
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Stroke, Mechanical Thrombectomy, Thrombolytic Therapy

Keywords

thromboelastometry, ischemic stroke, biomarker, thrombolysis, endovascular thrombectomy, Prediction of revascularization

Brief summary

In ischemic stroke, the recanalization rate after intravenous thrombolysis has been estimated to be less than 50% in patients with proximal intracranial artery occlusion; this rate is greater than 80% after endovascular thrombectomy. Thromboelastometry is a method of analysis of coagulation and fibrinolysis in whole blood. The main objective of this study is to evaluate whether the parameters obtained by thromboelastometry are predictive of revascularization at arteriography during mechanical thrombectomy, after treatment with rt-PA thrombolysis.

Detailed description

This is a single-center prospective observational study at the University Hospital of Caen. Any patient presenting a neurological deficit of sudden onset, compatible with a ischemic stroke diagnosed on brain imaging and eligible for thrombolysis by rtPA and/or a endovascular thrombectomy procedure will be included. Clot formation kinetics will be assessed by thromboelastometry (ROTEM® and/or QUANTRA®) to determine the predictive parameters of revascularization. The parameters of clot formation and lysis as well as revascularization according to thrombo-inflammation processes will be studied.

Interventions

OTHERthromboelastometry test

This study does not modify the usual care of the patient. Only 5 citrated tubes (maximum 15 mL of blood) are collected in addition to the initial emergency department sample (routine care). The patient's care follows the classic thrombolysis alert pathway. There is no additional complementary examination or additional neurological evaluation. Clot formation kinetics will be evaluated by thromboelastometry to determine the predictive parameters of revascularization. Clot formation and lysis parameters as well as revascularization according to thrombo-inflammation processes will be studied.

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Diagnosis of ischemic stroke * Decision of intravenous thrombolysis and/or endovascular thrombectomy by the neurologist and/or interventional neuroradiologist. * Patient admitted to the emergency department during the hours and days when the hematology-biology laboratory is open (Monday to Friday from 8:30 a.m. to 6:30 p.m.) * No opposition to the research from the patient or his relatives * Inclusions according to the emergency procedure

Exclusion criteria

* Age \< 18 ans * Formal contraindication to thrombolysis and/or endovascular thrombectomy, disorders of hemostasis and anticoagulant treatment.

Design outcomes

Primary

MeasureTime frameDescription
Prediction of the success of the revascularization procedure by thromboelastometryOne hour after the blood testAll the parameters of clot formation and lysis will be studied, in particular the area under the curve (AUC)
Does clot firmness could predict the success of the revascularizationOne hour after the blood testclot firmness (MCF in millimeter, mm)

Secondary

MeasureTime frameDescription
Thomboelastometry and prediction of success of recanalization by thrombectomy alonejust at the end of thrombectomy procedureEffectiveness of thrombectomy will be assessed by the TICI score ((Grade 0: no perfusion Grade 1: penetration with minimal perfusion Grade 2: partial perfusion Grade 2A: only partial filling (less than two-thirds) of the entire vascular territory is visualized Grade 2B: complete filling of all of the expected vascular territory is visualized but the filling is slower than normal Grade 3: complete perfusion)
Thomboelastometry and prediction of thrombolysis + thrombectomy efficacyduring thrombectomy procedureeffectiveness of thrombectomy will be assessed per-arteriogram by the TICI score (Grade 0: no perfusion Grade 1: penetration with minimal perfusion Grade 2: partial perfusion Grade 2A: only partial filling (less than two-thirds) of the entire vascular territory is visualized Grade 2B: complete filling of all of the expected vascular territory is visualized but the filling is slower than normal Grade 3: complete perfusion)
Thomboelastometry and prediction of neurological outcomeD0, Day 1, Day 3 after revascularizationThe use of the NIHSS score will allow the neurological evaluation of the patient (at admission and 24h/72h after the recanalization attempt). Neurological outcome, as assessed by the NIHSS score, is considered favorable if the NIHSS score at 24h/72h post-recanalization is equal to 0 or 1 or if there is an improvement in the NIHSS score of at least four points between the admission score and the score at 24h/72h post-recanalization.
Prediction of success of thrombolysisDay 1, Day 3 after thrombolysispresence or absence of a clot on MRI or angioscan
Thomboelastometry and prediction of thrombectomy efficacyimmediatly after thrombectomy procedurenumber of passes required for successful recanalization thrombolysis

Countries

France

Contacts

Primary ContactClémence h Tomadessos
tomadesso-c@chu-caen.fr+33231065386
Backup ContactRichard Macrez
macrez-r@chu-caen.fr+33231065386

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026